I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 26% ± 8% | |
| epithelial cell | 5 studies | 24% ± 11% | |
| GABAergic neuron | 5 studies | 35% ± 15% | |
| microglial cell | 5 studies | 33% ± 10% | |
| endothelial cell | 4 studies | 22% ± 6% | |
| glutamatergic neuron | 4 studies | 52% ± 13% | |
| natural killer cell | 4 studies | 20% ± 4% | |
| interneuron | 4 studies | 36% ± 24% | |
| neuron | 4 studies | 43% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 1% | |
| non-classical monocyte | 3 studies | 28% ± 5% | |
| retinal cone cell | 3 studies | 40% ± 15% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 2% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 9% | |
| lymphocyte | 3 studies | 25% ± 7% | |
| goblet cell | 3 studies | 16% ± 1% |
